Publication: CARB-ES-19 Multicenter Study of Carbapenemase-Producing Klebsiella pneumoniae and Escherichia coli From All Spanish Provinces Reveals Interregional Spread of High-Risk Clones Such as ST307/OXA-48 and ST512/KPC-3.
| dc.contributor.author | Cañada-Garcia, Javier Enrique | |
| dc.contributor.author | Moure García, Zaira | |
| dc.contributor.author | Sola-Campoy, Pedro Juan | |
| dc.contributor.author | Delgado-Valverde, Mercedes | |
| dc.contributor.author | Cano, María E | |
| dc.contributor.author | Gijón, Desirèe | |
| dc.contributor.author | González, Mónica | |
| dc.contributor.author | Gracia-Ahufinger, Irene | |
| dc.contributor.author | Larrosa, Nieves | |
| dc.contributor.author | Mulet, Xavier | |
| dc.contributor.author | Pitart, Cristina | |
| dc.contributor.author | Rivera, Alba | |
| dc.contributor.author | Bou, Germán | |
| dc.contributor.author | Calvo, Jorge | |
| dc.contributor.author | Cantón, Rafael | |
| dc.contributor.author | González-López, Juan José | |
| dc.contributor.author | Martínez-Martínez, Luis | |
| dc.contributor.author | Navarro, Ferran | |
| dc.contributor.author | Oliver, Antonio | |
| dc.contributor.author | Palacios-Baena, Zaira R | |
| dc.contributor.author | Pascual, Álvaro | |
| dc.contributor.author | Ruiz-Carrascoso, Guillermo | |
| dc.contributor.author | Vila, Jordi | |
| dc.contributor.author | Aracil, Belen | |
| dc.contributor.author | Perez-Vazquez, Maria | |
| dc.contributor.author | Oteo-Iglesias, Jesus | |
| dc.contributor.author | GEMARA/GEIRAS-SEIMC/REIPI CARB-ES-19 Study Group | |
| dc.contributor.funder | Instituto de Salud Carlos III | |
| dc.contributor.funder | Plan Nacional de I+D+i (España) | |
| dc.contributor.funder | Ministerio de Economía y Competitividad (España) | |
| dc.contributor.funder | RETICS-Investigación en Patología Infecciosa (REIPI-ISCIII) (España) | |
| dc.contributor.funder | Unión Europea. Fondo Europeo de Desarrollo Regional (FEDER/ERDF) | |
| dc.contributor.funder | Centro de Investigación Biomédica en Red - CIBERINFEC (Enfermedades Infecciosas) | |
| dc.contributor.funder | Unión Europea | |
| dc.date.accessioned | 2023-02-03T19:33:51Z | |
| dc.date.available | 2023-02-03T19:33:51Z | |
| dc.date.issued | 2022-06-30 | |
| dc.description | Corrigendum: CARB-ES-19 multicenter study of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli from all Spanish provinces reveals interregional spread of high-risk clones such as ST307/OXA-48 and ST512/KPC-3. Front Microbiol. 2023 Nov 28;14:1331657. doi: 10.3389/fmicb.2023.1331657. PMID: 38098654. | |
| dc.description.abstract | Objectives: CARB-ES-19 is a comprehensive, multicenter, nationwide study integrating whole-genome sequencing (WGS) in the surveillance of carbapenemase-producing K. pneumoniae (CP-Kpn) and E. coli (CP-Eco) to determine their incidence, geographical distribution, phylogeny, and resistance mechanisms in Spain. Methods: In total, 71 hospitals, representing all 50 Spanish provinces, collected the first 10 isolates per hospital (February to May 2019); CPE isolates were first identified according to EUCAST (meropenem MIC > 0.12 mg/L with immunochromatography, colorimetric tests, carbapenem inactivation, or carbapenem hydrolysis with MALDI-TOF). Prevalence and incidence were calculated according to population denominators. Antibiotic susceptibility testing was performed using the microdilution method (EUCAST). All 403 isolates collected were sequenced for high-resolution single-nucleotide polymorphism (SNP) typing, core genome multilocus sequence typing (cgMLST), and resistome analysis. Results: In total, 377 (93.5%) CP-Kpn and 26 (6.5%) CP-Eco isolates were collected from 62 (87.3%) hospitals in 46 (92%) provinces. CP-Kpn was more prevalent in the blood (5.8%, 50/853) than in the urine (1.4%, 201/14,464). The cumulative incidence for both CP-Kpn and CP-Eco was 0.05 per 100 admitted patients. The main carbapenemase genes identified in CP-Kpn were bla OXA-48 (263/377), bla KPC-3 (62/377), bla VIM-1 (28/377), and bla NDM-1 (12/377). All isolates were susceptible to at least two antibiotics. Interregional dissemination of eight high-risk CP-Kpn clones was detected, mainly ST307/OXA-48 (16.4%), ST11/OXA-48 (16.4%), and ST512-ST258/KPC (13.8%). ST512/KPC and ST15/OXA-48 were the most frequent bacteremia-causative clones. The average number of acquired resistance genes was higher in CP-Kpn (7.9) than in CP-Eco (5.5). Conclusion: This study serves as a first step toward WGS integration in the surveillance of carbapenemase-producing Enterobacterales in Spain. We detected important epidemiological changes, including increased CP-Kpn and CP-Eco prevalence and incidence compared to previous studies, wide interregional dissemination, and increased dissemination of high-risk clones, such as ST307/OXA-48 and ST512/KPC-3. | es_ES |
| dc.description.peerreviewed | Sí | es_ES |
| dc.description.sponsorship | This research was supported by grants from the Instituto de Salud Carlos III (numbers PI18CIII/00030 and PI21CIII/00039). It was also supported by Plan Nacional de I+D+i 2013–2016, Instituto de Salud Carlos III, Subdirección General de Redes y Centros de Investigación Cooperativa, Ministerio de Economía y Competitividad, Spanish Network for Research in Infectious Diseases (grants RD16CIII/0004/0002, RD16/0016/0001, RD16/0016/0003, RD16/0016/0004, RD16/0016/0006, RD16/0016/0007, RD16/0016/0008, RD16/0016/0010, and RD16/0016/0011). Cofinanced by the European Development Regional Fund “A way to achieve Europe,” Operative Program Intelligent Growth 2014-2020. CIBER-Consorcio Centro de Investigación Biomédica en Red (CB21/13/00095, CB21/13/00012, CB21/13/00049, CB21/13/00054, CB21/13/00055, CB21/13/00068, CB21/13/00081, CB21/13/00084, and CB21/13/00099) (CIBERINFEC) Instituto de Salud Carlos III, Ministerio de Ciencia e Innovación and Unión Europea-NextGenerationEU also supported this work. | es_ES |
| dc.format.page | 918362 | es_ES |
| dc.format.volume | 13 | es_ES |
| dc.identifier.citation | Front Microbiol. 2022 Jun 30;13:918362. | es_ES |
| dc.identifier.doi | 10.3389/fmicb.2022.918362 | es_ES |
| dc.identifier.issn | 1664-302X | es_ES |
| dc.identifier.journal | Frontiers in microbiology | es_ES |
| dc.identifier.pubmedID | 35847090 | es_ES |
| dc.identifier.uri | http://hdl.handle.net/20.500.12105/15452 | |
| dc.language.iso | eng | es_ES |
| dc.publisher | Frontiers Media | |
| dc.relation.projectFECYT | info:eu-repo/grantAgreement/MINECO//RD16%2F0016%2F0001/ES/RED ESPAÑOLA DE INVESTIGACIÓN EN PATOLOGÍAS INFECCIOSAS/ | es_ES |
| dc.relation.projectFECYT | info:eu-repo/grantAgreement/MINECO//RD16%2F0016%2F0003/ES/RED ESPAÑOLA DE INVESTIGACIÓN EN PATOLOGÍAS INFECCIOSAS/ | es_ES |
| dc.relation.projectFECYT | info:eu-repo/grantAgreement/MINECO//RD16%2F0016%2F0004/ES/RED ESPAÑOLA DE INVESTIGACIÓN EN PATOLOGÍAS INFECCIOSAS/ | es_ES |
| dc.relation.projectFECYT | info:eu-repo/grantAgreement/MINECO//RD16%2F0016%2F0006/ES/RED ESPAÑOLA DE INVESTIGACIÓN EN PATOLOGÍAS INFECCIOSAS/ | es_ES |
| dc.relation.projectFECYT | info:eu-repo/grantAgreement/MINECO//RD16%2F0016%2F0007/ES/RED ESPAÑOLA DE INVESTIGACIÓN EN PATOLOGÍAS INFECCIOSAS/ | es_ES |
| dc.relation.projectFECYT | info:eu-repo/grantAgreement/MINECO//RD16%2F0016%2F0008/ES/RED ESPAÑOLA DE INVESTIGACIÓN EN PATOLOGÍAS INFECCIOSAS/ | es_ES |
| dc.relation.projectFECYT | info:eu-repo/grantAgreement/MINECO//RD16%2F0016%2F0010/ES/RED ESPAÑOLA DE INVESTIGACIÓN EN PATOLOGÍAS INFECCIOSAS/ | es_ES |
| dc.relation.projectFECYT | info:eu-repo/grantAgreement/MINECO//RD16%2F0016%2F0011/ES/RED ESPAÑOLA DE INVESTIGACIÓN EN PATOLOGÍAS INFECCIOSAS/ | es_ES |
| dc.relation.projectFIS | info:fis/Instituto de Salud Carlos III/Programa Estatal de Fomento de la Investigación Científica y Técnica de Excelencia/Subprograma Estatal de Generación de Conocimiento/PI18-ISCIII Modalidad Proyectos de Investigacion en Salud Intramurales. (2018)/PI18CIII/00030 | es_ES |
| dc.relation.projectFIS | info:fis/Instituto de Salud Carlos III///PI21-ISCIII Modalidad Proyectos de Investigacion en Salud Intramurales. (2021)/PI21CIII/00039 | es_ES |
| dc.relation.projectFIS | info:eu-repo/grantAgreement/ES/RD16CIII/0004/0002 | es_ES |
| dc.relation.projectFIS | info:eu-repo/grantAgreement/ES/CB21/13/00095 | es_ES |
| dc.relation.projectFIS | info:eu-repo/grantAgreement/ES/CB21/13/00012 | es_ES |
| dc.relation.projectFIS | info:eu-repo/grantAgreement/ES/CB21/13/00049 | es_ES |
| dc.relation.projectFIS | info:eu-repo/grantAgreement/ES/CB21/13/00054 | es_ES |
| dc.relation.projectFIS | info:eu-repo/grantAgreement/ES/CB21/13/00055 | es_ES |
| dc.relation.projectFIS | info:eu-repo/grantAgreement/ES/CB21/13/00068 | es_ES |
| dc.relation.projectFIS | info:eu-repo/grantAgreement/ES/CB21/13/00081 | es_ES |
| dc.relation.projectFIS | info:eu-repo/grantAgreement/ES/CB21/13/00084 | es_ES |
| dc.relation.projectFIS | info:eu-repo/grantAgreement/ES/CB21/13/00099 | es_ES |
| dc.relation.publisherversion | https://doi.org/10.3389/fmicb.2022.918362 | es_ES |
| dc.repisalud.centro | ISCIII::Centro Nacional de Microbiología | es_ES |
| dc.repisalud.institucion | ISCIII | es_ES |
| dc.rights.accessRights | open access | es_ES |
| dc.rights.license | Atribución 4.0 Internacional | * |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | * |
| dc.subject | CARB-ES-19 study | es_ES |
| dc.subject | Carbapenemases | es_ES |
| dc.subject | Whole genome sequencing | es_ES |
| dc.subject | Klebsiella pneumoniae | es_ES |
| dc.subject | High-risk clones | es_ES |
| dc.title | CARB-ES-19 Multicenter Study of Carbapenemase-Producing Klebsiella pneumoniae and Escherichia coli From All Spanish Provinces Reveals Interregional Spread of High-Risk Clones Such as ST307/OXA-48 and ST512/KPC-3. | es_ES |
| dc.type | journal article | es_ES |
| dc.type.hasVersion | VoR | es_ES |
| dspace.entity.type | Publication | |
| relation.isAuthorOfPublication | 514ea39a-76d7-423b-9103-0b523713f906 | |
| relation.isAuthorOfPublication | 188f9e0c-bb13-4f1e-9bb6-9e7e78a9aa6e | |
| relation.isAuthorOfPublication | 8d9ee0ab-df60-4e64-89e0-2ff4ebba50c5 | |
| relation.isAuthorOfPublication | 6013faa2-bb1b-47a7-97c4-5a7bfb7a9756 | |
| relation.isAuthorOfPublication | 0ee7fb0c-569f-4530-9b12-8f87b4e6dd53 | |
| relation.isAuthorOfPublication | bcfa655d-9814-4372-a0a8-43b192fc26d0 | |
| relation.isAuthorOfPublication | 4ac67376-8b3e-48bd-9415-8770421fdd67 | |
| relation.isAuthorOfPublication.latestForDiscovery | 514ea39a-76d7-423b-9103-0b523713f906 | |
| relation.isFunderOfPublication | 7d739953-4b68-4675-b5bb-387a9ab74b66 | |
| relation.isFunderOfPublication | 0e5401ef-8ce7-439f-85e0-4e3550b5fade | |
| relation.isFunderOfPublication | 77b2fc20-6311-4e46-98a7-83e46257b93b | |
| relation.isFunderOfPublication | 59c823cb-42b5-4b1b-a401-bf53ee82c170 | |
| relation.isFunderOfPublication | efa64f05-b985-4984-8f1e-5fc4ef21f502 | |
| relation.isFunderOfPublication | 0b5a6d3a-4d4d-4346-9bcc-9359bbe13e72 | |
| relation.isFunderOfPublication | b029ca7c-43c2-46be-af9e-b34b7f455d94 | |
| relation.isFunderOfPublication.latestForDiscovery | 7d739953-4b68-4675-b5bb-387a9ab74b66 | |
| relation.isPublisherOfPublication | 9f9fa5ea-093b-43d8-bf2c-5bd65d08a802 | |
| relation.isPublisherOfPublication.latestForDiscovery | 9f9fa5ea-093b-43d8-bf2c-5bd65d08a802 |
Files
Original bundle
1 - 2 of 2
Loading...
- Name:
- CARB-ES-19MulticenterStudyCarbapenemase-Producing_2022.pdf
- Size:
- 3.73 MB
- Format:
- Adobe Portable Document Format
- Description:
Loading...
- Name:
- Corrigendum_CARB-ES-19MulticenterStudyCarbapenemase-Producing_2023.pdf
- Size:
- 89.38 KB
- Format:
- Adobe Portable Document Format
- Description:
- Erratum
Collections
Centro Nacional de Microbiología (CNM)
IBIS - Instituto de Biomedicina de Sevilla (Andalucía)
IdiPAZ - Instituto de Investigación Sanitaria Hospital La Paz (Madrid)
IdisBa - Instituto de Investigación Sanitaria Illes Balears (Baleares)
IDIVAL - Instituto de Investigación Marqués de Valdecilla (Cantabria)
IMIBIC - Instituto Maimónides de Investigación Biomédica de Córdoba (Andalucía)
Load more IBIS - Instituto de Biomedicina de Sevilla (Andalucía)
IdiPAZ - Instituto de Investigación Sanitaria Hospital La Paz (Madrid)
IdisBa - Instituto de Investigación Sanitaria Illes Balears (Baleares)
IDIVAL - Instituto de Investigación Marqués de Valdecilla (Cantabria)
IMIBIC - Instituto Maimónides de Investigación Biomédica de Córdoba (Andalucía)


